We identified μMax20 analogs, bearing two mutations at strategic sites (e.g., Lys31hArgand Lys57hArg mutations) and staples, which exhibited potent DNA-bindingactivity, intrinsic cell permeability at submicromolar concentrations,and effectively suppressed Myc-driven gene expression and cancer cellproliferation. Here, MYC is linked to cancer.